Form EFFECT Aspire Biopharma Holding
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Polygon (POL) Price Prediction: 100M POL Tokens Burned as AlphaPepe Pushes Past $2.8M Before Its Next CEX Reveal
- Crypto News Today: BlackRock Portfolios Move Onchain as Remittix Opens the BINANCE500 Rewards Window
- PENGU Price Prediction: Could a Break Above $0.011 Spark the Next Meme-Coin Explosion—or Will Remittix Launch First?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
